Primer: Zhaoke Ophthalmology (6622 HK) - Aug 2026
Zhaoke Ophthalmology is at a pivotal transition from a pure R&D entity to a commercial-stage company, with three core assets for myopia,...
100 Views
𝛼SK or SearchENTITY
Zhaoke Ophthalmology (6622 HK)
Zhaoke Ophthalmology (6622 HK)
35
Analysis
Health Care • China
Zhaoke Ophthalmology is an ophthalmic pharmaceutical company focused on the research, development, manufacturing, and commercialization of therapies for unmet medical needs in eye diseases. Its comprehensive drug portfolio addresses conditions such as dry eye disease, myopia, presbyopia, wet age-related macular degeneration, diabetic macular edema, and glaucoma. The company was founded in 2017 and is headquartered in Guangzhou, China.
morex